Menu Search
Equities

Ontex Group NV

ONTEX:BRU

Ontex Group NV

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (EUR)7.39
  • Today's Change-0.02 / -0.27%
  • Shares traded153.61k
  • 1 Year change+5.12%
  • Beta0.4439
Data delayed at least 15 minutes, as of Nov 15 2024 16:37 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy1
Outperform3
Hold3
Sell0
Strong Sell0

Share price forecast in EUR

The 7 analysts offering 12 month price targets for Ontex Group NV have a median target of 11.80, with a high estimate of 13.80 and a low estimate of 8.30. The median estimate represents a 59.68% increase from the last price of 7.39.
High86.7%13.80
Med59.7%11.80
Low12.3%8.30

Dividends in EUR

Dividend information is not available for Ontex Group NV.
Div growth (TTM)--
More ▼

Earnings history & estimates in EUR

On Jul 29, 2015, earnings of 0.42 per share. This result was in line with the consensus of the 2 analysts following the company
The next earnings announcement is expected on Feb 06, 2025.
Average growth rate+25.05%
Ontex Group NV reported annual 2023 earnings of 0.94 per share on Feb 08, 2024.
Average growth rate-49.34%
More ▼

Revenue history & estimates in EUR

Ontex Group NV had 3rd quarter 2024 revenues of 468.00m. This was 4.96% above the prior year's 3rd quarter results.
Average growth rate+1.35%
Ontex Group NV had revenues for the full year 2023 of 2.34bn. This was 4.99% below the prior year's results.
Average growth rate+1.30%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.